Trade Summary

3 days ago, Mayo Stephen, serving as Dir at Sarepta Therapeutics, Inc. (SRPT), sold 7,239 shares at $17.02 per share, for a total transaction value of $123,208.00. Following this transaction, Mayo Stephen now holds 1,765 shares of SRPT.

This sale represents a 80.00% decrease in Mayo Stephen's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 12, 2026 and publicly disclosed via SEC Form 4 filing on Friday, March 13, 2026, 1 day after the trade was made.

Sarepta Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.